Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. J.F.M. (Job) van Boven

Speerpunten

Medication adherence, real-world drug outcomes, digital adherence technology, sustainable drug use, cost-effective drug utilization, respiratory diseases (asthma, COPD, TB, CF, lung cancer)

Publicaties

Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges

Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial

Personalized medication adherence management in asthma and COPD: a review of effective interventions and development of a practical adherence toolkit

Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial

Long-term cost-effectiveness of digital inhaler adherence technologies in difficult-to-treat asthma

Children's High Adherence to Asthma Biologics: Exceptional or Simply Logical?

Digital respiratory technologies across the lifespan: an overview of opportunities and challenges from children to older adults

Key factors for implementing inhaler regimen switches in respiratory diseases: international expert consensus generated using a modified nominal group technique (NGT)

Adherence to Inhaled Medication Guidelines in Patients with COPD: Evaluating the GOLD 2023 Strategy in a Real-World Secondary Care Setting

Arrival of biosimilars in respiratory medicine: towards improved access to biologics for patients

Pers/media

Een patiënt die zijn ziekte onder controle heeft, is ook een ‘groene’ patiënt

Krasstickers als wapen tegen vergeten medicijnen (Hartbrug Magazine)

Meer buiten, minder astma (Volkskrant)

Milieubewust puffen (RTL EditieNL)

Meest gebruikte inhaler schadelijk voor klimaat (NOS Journaal)

Stand van Nederland - Wereld op Scherp: Een bittere pil (WNL NPO2)

Neem ze op tijd: Hulp bij Therapietrouw (Gezondgids 6, Consumentenbond)

Tekorten aan medicijnen in het UMCG groot probleem (OogTV)